Table 3.
Oncology EHR Core Functional Elements
| Element/Functionality | |
|---|---|
| Treatment plan core elements | Flow sheet: inclusive of all chemotherapy, |
| Demographics, including referring provider and PCP | non-chemotherapy medications, transfusions, tumor measurements, lab values |
| Diagnosis: ICD-9 or 10; possibly more clinically relevant system | |
| Flow sheet: physical findings, including tumor measurements, imaging, relevant procedures, nursing assessment* | |
| Stage | |
| AJCC for relevant diagnoses: tumor registry staging system for other diagnoses | |
| Oncology-specific review of systems | |
| Disease status at each course of therapy | Patient provided with copy of treatment plan and summary |
| Site/histology/pathology findings: menu-driven by disease | |
| Intent/goals of therapy: adjuvant/curative v palliative | Documentation of investigational drugs |
| Performance status | Capture date of death* |
| List of comorbid conditions expected to complicate chemotherapy, eg, hepatic insufficiency | Oncology-specific EHR functions |
| EHR-generated treatment plan | |
| Cancer surgical history | EHR-generated treatment summary |
| Chemotherapy/biotherapy regimen planned | Ability to update treatment summary |
| Body surface area and starting doses | EHR application to generate specific reports, eg, specific types of flow sheets |
| Duration of treatment and number of planned cycles | |
| Major toxicities associated with planned treatment | Mechanism to capture verbal orders* |
| Radiation therapy planned or previously delivered | Drug interaction alerts |
| Pain assessment and supportive care needs: advanced cancer | Basic safety limits for dosing |
| Body surface area safety monitoring | |
| Treatment on clinical trial | Lifetime cumulative chemotherapy dose |
| Sites of disease monitored: advanced cancer eligibility* | Clinical decision support, eg, guidelines or trial |
| Treatment summary core elements | |
| Patient demographics | Treatment preauthorization support* |
| Chemotherapy/biotherapy delivered: IV and oral | Drug inventory control* |
| Number of cycles planned and administered | Internal and external communications* |
| Duration: date of first and last dose | Import key external reports, eg, pathology, operative note, radiation |
| Extent of dose reduction | |
| Reason treatment stopped | Radiofrequency identification technology for patient/drugs given, eg, barcodes* |
| Major toxicities experienced | |
| Hospitalization required for toxicity | Open database with query capabilities* |
| Disease status at completion of treatment | Interoperability: health information exchange with labs, imaging centers, etc.* |
| Performance status at completion of treatment | |
| Coordination of follow-up care | Compliance safeguards |
| Provider contacts | Privacy and security safeguards in place |
| Other oncology-specific documentation | Disaster recovery plan in place |
Abbreviations: EHR, electronic health record; PCP, primary care physician; ICD-9, International Classification of Diseases, 9th Edition; AJCC, American Joint Committee on Cancer.
* Denotes elements characterized by Roundtable participants as desirable, not critical.